Umeclidinium bromide/vilanterol

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Umeclidinium bromide/vilanterol
Umeclidinium.svg
Vilanterol2DACS.svg
Umeclidinium bromide (top), vilanterol (bottom)
Combination of
Umeclidinium bromide Anticholinergic
Vilanterol Beta2-adrenergic agonist
Clinical data
Trade names Anoro Ellipta
AHFS/Drugs.com entry
Pregnancy cat.
Legal status
Routes Inhalation
Identifiers
ATC code R03AL03

Umeclidinium bromide/vilanterol (trade name Anoro Ellipta) is a combination drug approved for the treatment of chronic obstructive pulmonary disease (COPD).[1][2] It is applied as an inhalation.

References[edit]

  1. ^ Feldman, GJ; Edin, A (2013). "The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: Current evidence and future prospects". Therapeutic advances in respiratory disease 7 (6): 311–9. doi:10.1177/1753465813499789. PMID 24004659. 
  2. ^ "FDA Approves Umeclidinium and Vilanterol Combo for COPD". Medscape. December 18, 2013.